• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本,慢性肾脏病 G3b-5 期患者的贫血和铁缺乏与健康相关生活质量的关系:Reach-J CKD 队列研究的亚分析。

Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study.

机构信息

Department of Clinical Laboratory Medicine, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.

Department of Nephrology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

出版信息

BMC Nephrol. 2024 Nov 19;25(1):414. doi: 10.1186/s12882-024-03849-8.

DOI:10.1186/s12882-024-03849-8
PMID:39563222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11575120/
Abstract

BACKGROUND

Iron deficiency is a major contributor to anaemia in chronic kidney diseases. The association of anaemia and iron deficiency with health-related quality of life in Japanese patients with non-dialysis chronic kidney disease has not been examined. In this study, we evaluated anaemia and iron deficiency in patients with chronic kidney disease G3b-5 and examined their associations with health-related quality of life.

METHODS

This nationwide cohort study included 2,249 patients with advanced chronic kidney disease receiving nephrologist care from 31 representative facilities throughout Japan; they were randomly selected through stratification by region and facility size and aligned with the Chronic Kidney Disease Outcomes and Practice Patterns Study. Using baseline patient data, we assessed the association of anaemia and iron deficiency with health-related quality of life, employing the 36-item Kidney Disease Quality of Life Questionnaire.

RESULTS

The mean mental and physical component summary scores for all patients were 49 and 47, respectively. Patients with haemoglobin levels < 10 g/dL had worse three kidney disease subscale, mental component summary, physical component summary, and subdomain scores than those with haemoglobin levels > 12 g/dL. Patients with absolute iron deficiency (TSAT < 20% and ferritin < 100 ng/mL) had worse three kidney disease subscale and mental component summary scores than those with functional iron deficiency (TSAT < 20% and ferritin ≥ 100 ng/mL).

CONCLUSIONS

Japanese patients with chronic kidney disease G3b-5 with anaemia or absolute iron deficiency had worse health-related quality of life. Our results provide clinical evidence of renal anaemia in Japan and will be useful for international comparisons.

摘要

背景

铁缺乏是慢性肾脏病贫血的主要原因。在日本非透析慢性肾脏病患者中,贫血和铁缺乏与健康相关生活质量的关系尚未得到检验。在这项研究中,我们评估了慢性肾脏病 G3b-5 患者的贫血和铁缺乏情况,并考察了它们与健康相关生活质量的关系。

方法

这项全国性队列研究纳入了 2249 名接受来自日本 31 个代表性医疗机构的肾病医生治疗的晚期慢性肾脏病患者;他们是通过按地区和医疗机构规模分层随机选择的,与慢性肾脏病结局和实践模式研究相一致。我们使用基线患者数据,通过 36 项肾脏病生活质量调查问卷评估了贫血和铁缺乏与健康相关生活质量的关系。

结果

所有患者的平均心理和生理成分综合评分分别为 49 和 47。血红蛋白水平<10 g/dL 的患者在肾脏病三个亚量表、心理成分综合评分、生理成分综合评分和亚域评分方面均比血红蛋白水平>12 g/dL 的患者差。绝对铁缺乏(转铁蛋白饱和度<20%和铁蛋白<100ng/mL)的患者在肾脏病三个亚量表和心理成分综合评分方面均比功能性铁缺乏(转铁蛋白饱和度<20%和铁蛋白≥100ng/mL)的患者差。

结论

日本慢性肾脏病 G3b-5 患者贫血或绝对铁缺乏与健康相关生活质量较差有关。我们的研究结果为日本的肾性贫血提供了临床证据,将有助于国际比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/73cb6652dfc6/12882_2024_3849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/46749f6428af/12882_2024_3849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/ede5a8b0dd5d/12882_2024_3849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/73cb6652dfc6/12882_2024_3849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/46749f6428af/12882_2024_3849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/ede5a8b0dd5d/12882_2024_3849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4c/11575120/73cb6652dfc6/12882_2024_3849_Fig3_HTML.jpg

相似文献

1
Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study.在日本,慢性肾脏病 G3b-5 期患者的贫血和铁缺乏与健康相关生活质量的关系:Reach-J CKD 队列研究的亚分析。
BMC Nephrol. 2024 Nov 19;25(1):414. doi: 10.1186/s12882-024-03849-8.
2
Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.血清铁储存标志物与非透析依赖的慢性肾脏病患者(无论是否合并贫血)的身体健康相关生活质量较差相关。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1694-1703. doi: 10.1093/ndt/gfab050.
3
Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.非透析依赖型慢性肾脏病贫血的病因谱:一项来自印度的单中心研究。
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):932-942. doi: 10.4103/1319-2442.265471.
4
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.FIND-CKD:一项针对慢性肾脏病合并缺铁性贫血患者比较静脉注射羧麦芽糖铁与口服铁剂的随机试验。
Nephrol Dial Transplant. 2014 Nov;29(11):2075-84. doi: 10.1093/ndt/gfu201. Epub 2014 Jun 2.
5
Frequency of iron deficiency anaemia in chronic kidney disease patient not on dialysis.未接受透析的慢性肾脏病患者缺铁性贫血的频率。
J Pak Med Assoc. 2022 Jul;72(7):1396-1400. doi: 10.47391/JPMA.4507.
6
Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.铁调素和 GDF-15 是南非慢性肾脏病患者缺铁性贫血的潜在生物标志物。
BMC Nephrol. 2020 Sep 29;21(1):415. doi: 10.1186/s12882-020-02046-7.
7
Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.日本初诊慢性肾病患者的贫血管理与死亡风险:CKD-ROUTE研究
Nephrology (Carlton). 2015 Sep;20(9):601-8. doi: 10.1111/nep.12493.
8
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.非透析慢性肾脏病(CKD)患者的贫血管理:肾科诊所的多中心前瞻性研究。
Nephrol Dial Transplant. 2013 Dec;28(12):3035-45. doi: 10.1093/ndt/gft338. Epub 2013 Oct 21.
9
Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.尼日利亚一家三级医院慢性肾脏病成人患者缺铁性贫血及其危险因素评估
Niger Postgrad Med J. 2018 Oct-Dec;25(4):197-203. doi: 10.4103/npmj.npmj_106_18.
10
A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non-dialysis-dependent chronic kidney disease-related anaemia in Japan.日本非透析依赖性慢性肾脏病相关贫血患者中红细胞生成刺激剂治疗模式及相关医疗资源使用的回顾性数据库分析。
Nephrology (Carlton). 2023 Aug;28(8):446-455. doi: 10.1111/nep.14168. Epub 2023 May 10.

本文引用的文献

1
Anemia Treatment, Hemoglobin Variability, and Clinical Events in Patients With Nondialysis-Dependent CKD in Japan.日本非透析依赖性 CKD 患者的贫血治疗、血红蛋白变异性与临床事件
Kidney360. 2023 Sep 1;4(9):e1223-e1235. doi: 10.34067/KID.0000000000000204. Epub 2023 Jul 10.
2
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病新型贫血治疗方法:改善全球肾脏病预后组织(KDIGO)争议会议的结论。
Kidney Int. 2023 Oct;104(4):655-680. doi: 10.1016/j.kint.2023.05.009. Epub 2023 May 24.
3
Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease.
血清铁标志物、铁补充剂与透析前慢性肾脏病患者心血管发病率的关系。
Nephrol Dial Transplant. 2023 Nov 30;38(12):2713-2722. doi: 10.1093/ndt/gfad096.
4
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.ASCEND-NHQ 随机临床试验发现 daprodustat 对非透析慢性肾病患者的血红蛋白和生活质量有积极影响。
Kidney Int. 2023 Jun;103(6):1180-1192. doi: 10.1016/j.kint.2023.02.019. Epub 2023 Mar 2.
5
Physical functioning in patients with chronic kidney disease stage G3b-5 in Japan: The reach-J CKD cohort study.日本慢性肾脏病 G3b-5 期患者的身体机能:REACH-J CKD 队列研究。
Nephrology (Carlton). 2021 Dec;26(12):981-987. doi: 10.1111/nep.13955. Epub 2021 Aug 17.
6
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.血清铁储存生物标志物与非透析 CKD 患者(无论是否贫血)全因死亡率和心血管事件风险增加相关。
J Am Soc Nephrol. 2021 Aug;32(8):2020-2030. doi: 10.1681/ASN.2020101531. Epub 2021 Jul 8.
7
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study.比较慢性肾脏病 G3b-5 患者中主要肾脏疾病的年估算肾小球滤过率下降:来自 REACH-J 慢性肾脏病队列研究的结果。
Clin Exp Nephrol. 2021 Aug;25(8):902-910. doi: 10.1007/s10157-021-02059-y. Epub 2021 Apr 21.
8
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.最佳贫血管理中的争议:来自改善全球肾脏病预后组织(KDIGO)会议的结论
Kidney Int. 2021 Jun;99(6):1280-1295. doi: 10.1016/j.kint.2021.03.020. Epub 2021 Apr 8.
9
Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.血清铁储存标志物与非透析依赖的慢性肾脏病患者(无论是否合并贫血)的身体健康相关生活质量较差相关。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1694-1703. doi: 10.1093/ndt/gfab050.
10
Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated.慢性肾脏病预后和实践模式研究中3-5ND期慢性肾脏病患者的贫血和缺铁情况:常未得到检测,治疗方式各异
Clin Kidney J. 2019 Aug 3;13(4):613-624. doi: 10.1093/ckj/sfz091. eCollection 2020 Aug.